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Summary Takayasu arteritis is a panaortitis, more frequent in Japan, South-East Asia India
and Mexico, that presents in the 2nd or 3rd decade of life with a non-speciﬁc inﬂammatory
phase, then vascular stenosis with ‘pulselessness’ with collateral development. Clinical fea-
tures include reduced/absent pulses, bruits, hypertension, aortic regurgitation, neurologicalUltrasonography;
Diagnosis;
Management
symptoms from ischemia. While the gold standard for diagnosis is arteriography, magnetic res-
onance angiography and ultrasonography are now widely used due to their non-invasive nature.
Steroids are the cornerstone of medical therapy; cytotoxics may be used for failures. Surgery
or angioplasty may be needed for severe vascular stenosis.
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History
The earliest description of this ailment was probably made in
1930 by Yamamoto in Japan of a 45-year old man with impal-
pable carotid and upper limb pulses. The ﬁrst presentation
to a scientiﬁc audience of the disease was by Japanese oph-
thalmologist Mikito Takayasu in 1905 when he described a
21-year old female with coronary anastomosis in her ocular
fundus. At that same 12th Annual Meeting of the Japan Oph-
thalmology Society in Fukuoka, Drs. Kagoshima and Ohnishi
each presented a similar case that also had no radial pulse.
The disease was thus subsequently called Takayasu Arteri-
tis to honour the ﬁrst presenter. Ohta attributed the ocular
abnormalities to occlusion of the cervical arteries, while
Shimizu and Sano coined the now widely phrase ‘pulseless
disease’ for this entity. Another occasionally-used term is
Martorell syndrome.
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Open access under CC BY-NC-ND license.pidemiology
he frequency of the disease appears to be higher in Japan,
outh-East Asia, India and Mexico compared to other parts
f the world. In North America, the incidence was found to
e 2.6/million/year.
athology
akayasu arteritis is pathologically a panaortitis. The adven-
itia is thickened and ﬁlled with inﬂammatory T-cells and
onocytes. It is believed that these cells enter via the vaso
asorum, attracted by adhesion molecules such as ICAM-1
nd VCAM-1 expressed in these vessels. It has been found
hat infectionmay trigger the disease in mice — no clear con-
istent relationship as been found in humans; tuberculosis
as also been implicated. The aorta later becomes ﬁbrotic,
ith lumen narrowed patchily in multiple areas.
s under CC BY-NC-ND license.enetics
amilial cases have been reported from a number of coun-
ries, including among twins. Human Leucocyte Antigen
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Table 1 Clinical manifestations of Takayasu arteritis (Ref.
[1]).
Clinical feature Frequency (%)
Reduced/absent pulses 84—96
Bruits 80—94
Hypertension 33—83
Renal artery stenosis 28—75
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Table 2 Classiﬁcation of Takayasu arteritis.
Type Arterial involvement
I Branches of aortic arch
IIa Ascending aorta, aortic arch and its branches
IIb Ascending aorta, aortic arch and its branches and
thoracic descending aorta
III Thoracic descending aorta, abdominal aorta
and/or renal arteries
IV Only abdominal aorta and/or renal arteries
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[Aortic regurgitation 20—24
Pulmonary artery involvement 14—100
HLA) gene analyses have found increased frequency of HLA
52, B39.2, D12 and A24 among Japanese. The gene may lie
etween the MIC gene and HLA B locus on chromosome 6.
LA B52 patients may have more severe inﬂammation while
hose with HLA B39may havemore renal artery involvement.
linical manifestations
he illness ranges from being asymptomatic to a catas-
rophic illness. It often presents in the 2nd or 3rd decade
f life. It may begin with a non-speciﬁc inﬂammatory
‘pre-pulseless’’ phase characterised by fever, night sweats,
ethargy, loss of weight, pains in the muscles and joints and
ven a mild anaemia. The erythrocyte sedimentation rate
ESR) tends to be elevated. With progression of the inﬂam-
ation, vascular stenoses, usually bilateral, occur with
esulting development of collateral circulation. Notably, not
ll patients go through these various stages.
Clinical features are shown in Table 1. Others include
eurological involvement leading to transient ischemic
ttacks or stroke, giddiness, headache or rarely seizures,
hile cardiac features include congestive cardiac failure.
The 1990 American College of Rheumatology criteria
equire 3 or 6 features of age of onset ≤40 years, limb clau-
ication, reduced pulsation in at least 1 brachial artery, a
10mmHg difference in systolic blood pressure between the
rms, bruits audible over the subclavian artery or abdominal
orta, and abnormalities on arteriography of the aorta or its
rincipal branches.
Japanese patient are mostly female, while Indian
atients are more male. Japanese patients tend to have
educed upper limb pulses due to involvement of the ascend-
ng aorta and aortic arch, while those of Indian, Thai, Korean
nd Chinese origin tend to have renovascular hypertension
ue to abdominal aorta and renal artery involvement.iagnosis
he gold standard for clinical diagnosis is arteriography.
he International Conference on Takayasu Arteritis in 1994
[
[V Combined types IIb and IV
lassiﬁed the disease based on the angiogram (Table 2). His-
ology is conceivably the most diagnostic. In view of the
nvasive nature of angiography and impracticality of biopsy,
ltrasonography is now widely used to make the diagnosis in
clinically suspected patient.
Ultrasound reveals thickened vessel walls (macaroni
ign), including the carotid artery. Magnetic resonance
ngiography may reveal a better understanding of wall
dema, and inﬂammation if contrast is used. These may be
sed to monitor response to treatment.
reatment
teroids remain the cornerstone of medical therapy. While
arly studies showed poor beneﬁt, later studies have
hown better response rates of about 50%, with reduc-
ion of symptoms of inﬂammation and even return of
ulses in some patients. Among non-responders, a fur-
her 50% may respond to methotrexate. Other agents that
ave been tried include azathioprine, cyclophosphamide
nd mycophenolate mofetil. Hypertension needs to be well-
anaged, with careful use of angiotensin converting enzyme
nhibitors.
Surgery may be needed if there is severe renal artery
tenosis, activity-limiting limb ischemia, critical cerebral
essel stenosis, moderately severe aortic incompetence. It
s best performed when the disease is ‘quiet’. Angioplasty
ith or without stenting may be used for severe steno-
is.
urther reading
1] Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review.
J Clin Pathol 2002;55:481—6.2] Numano F, Kobayashi Y. Takayasu arteritis—–beyond pulseless-
ness. Int Med 1999;38:226—32.
3] Andrews J, Mason JC. Takayasu arteriotis—–recent advances in
imaging offer promise. Rheumatology 2007;46:6—15.
